期刊文献+

HCV核心和截短的包膜蛋白E2基因在昆虫细胞中的表达及其抗原性 被引量:1

Expression of hepatitis C virus core gene and truncated envelope 2 gene in insect cells and its antigenicity
下载PDF
导出
摘要 目的 :构建含 HCV全长核心基因和截短的包膜蛋白 E2基因的重组杆状病毒表达载体 ,研究其表达和抗原性。 方法 :以含 HCV全长 c DNA克隆的 p GEM- HCJ4质粒为模板 ,PCR扩增全长的 HCV核心抗原基因和截短的 E2基因片段 ,插入转座载体 p Fast Bac HTa构建重组转座质粒 p FB- CE2 t,转化 DH10 Bac大肠杆菌 ,获得重组杆状病毒穿梭质粒 Bacmid- CE2 t,以之转染昆虫 Sf9细胞进行外源基因的表达 ,并对其抗原性进行 EL ISA检测。 结果 :SDS- PAGE和 Western blot分析表明Bacmid- CE2 t在 Sf9细胞表达了 HCV C- E2蛋白 ,并能利用细胞内蛋白酶将其裂解为单独的 C蛋白和截短的 E2蛋白。纯化后的蛋白能分别与 HCV C蛋白、E2蛋白单抗以及慢性丙型肝炎患者血清反应。 结论 :HCV核心蛋白和截短的 Objective:To construct recombinant baculovirus expression vector containing hepatitis C virus (HCV) core gene and envelope 2 (E2) gene, and to study its expression and antigenicity in insect cells.Methods:pGEM-HCJ4 plasmid containing full-length cDNA clone of HCV was used as the template to amplify HCV core gene and truncated E2 gene by PCR. The fragments were cloned into the transposed vector pFastBacHTa to construct a recombinant plasmid pFB-CE2t. pFB-CE2t was further transformed into DH10Bac E.coli, the recombinant Bacmid-CE2t was screened and transfected in the Sf 9 cells for the expression of the heterologous gene. Antigenicity of recombinant proteins was detected by ELISA. Results: SDS-PAGE and Western blot analysis demonstrated that recombinant proteins were expressed and cleaved into the core protein and E2 protein in Sf 9 cells. Purified protein reacted strongly with monoclonal antibody (mAb) against HCV core protein, mAb against HCV E2 protein and the serum of patients with chronic HCV respectively. Conclusion:HCV core protein and truncated E2 protein can be expressed in insect cells and have strong antigenicity.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2004年第9期962-965,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金 (30 0 80 0 2 0 )
关键词 肝炎病毒 丙型 核心蛋白 截短的E2蛋白 昆虫Sf 9细胞 hepatitis C virus core protein truncated envelope 2 protein insect Sf 9 cells
  • 相关文献

参考文献8

  • 1[1]Leyssen P, De Clercq E, Neyts J. Perspectives for the treatment of infections with Flaviviridae[J]. Clin Microbiol Rev,2000,13(1) :67-82.
  • 2[2]Charlene C. Infectious diseases. Hard-won advances spark excitement about hepatitis C[J]. Science, 2001,294(5542) :506-507.
  • 3[3]Ezelle HJ, Markovic D, Barber GN. Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector[J]. J Virol, 2002,76(23):12325-12334.
  • 4[4]Liu ZX, Nishida H, He JW, et al. Hepatitis C virus genotype 1b core protein does not exert immunomodulatory effects on virus-induced cellular immunity[J].J Virol, 2002, 76 (3):990-997.
  • 5[5]WardS, Lauer G, Isba R, et al. Cellular immune responses against hepatitis C virus: the evidence base 2002[J]. Clin Exp Immunol, 2002,128(2): 195-203.
  • 6[6]Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis Cvirus to CD81[J]. Science, 1998, 282(5390):938-940.
  • 7[7]Baumert TF, Ito S, Wong DT, et al. Hepatitis C virus structural proteins assemble into virus-like particles in insect cells [J]. JVirol, 1998,72(5) :3827-3836.
  • 8[8]Heile JM, Fong YL, Rosa D, et al. Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates [J]. J Virol, 2000, 74(15) :6885-6892.

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部